AMALGAMATED BANK - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$101
-19.8%
22,306
+24.8%
0.00%0.0%
Q2 2023$126
+32.6%
17,872
+14.9%
0.00%0.0%
Q1 2023$95
-22.8%
15,551
-19.1%
0.00%0.0%
Q4 2022$123
-99.9%
19,2330.0%0.00%
-50.0%
Q3 2022$184,000
-12.4%
19,233
+1.0%
0.00%0.0%
Q2 2022$210,000
-56.2%
19,046
-34.0%
0.00%
-50.0%
Q1 2022$480,000
-55.5%
28,847
-48.9%
0.00%0.0%
Q4 2021$1,078,000
+63.8%
56,428
+111.3%
0.00%
-33.3%
Q3 2021$658,000
-9.0%
26,700
-3.9%
0.01%0.0%
Q2 2021$723,000
-11.0%
27,790
+8.4%
0.01%
-80.0%
Q1 2021$812,000
-37.2%
25,632
-8.0%
0.03%
-38.8%
Q4 2020$1,293,000
+40.8%
27,866
-0.0%
0.05%
+22.5%
Q3 2020$918,000
+19.2%
27,872
-0.6%
0.04%
+11.1%
Q2 2020$770,000
+21.8%
28,050
+32.9%
0.04%
+140.0%
Q1 2020$632,000
+3.6%
21,100
-4.2%
0.02%
+36.4%
Q4 2019$610,000
+65.3%
22,034
+8.6%
0.01%
+37.5%
Q3 2019$369,000
-26.8%
20,297
-1.3%
0.01%
-33.3%
Q2 2019$504,000
+247.6%
20,559
+34.7%
0.01%
+200.0%
Q1 2019$145,000
+11.5%
15,265
+4.3%
0.00%0.0%
Q4 2018$130,000
-19.3%
14,634
+16.3%
0.00%0.0%
Q2 2018$161,00012,5790.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders